Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-184-4 | CAS number: 67801-64-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames Test (OECD 471, GLP, K, rel. 1): non mutagenic up to 5000 µg/plate
in S. typhimurium TA 1535, TA 1537, TA 98, TA 100 & E.coli WP2uvrA.
Ames Test (similar to OECD 471, GLP, K, rel. 1): non mutagenic up to
5000 µg/plate in S. typhimurium TA 1535, TA 1537, TA 98, TA 100 & E.coli
WP2uvrA.
Micronucleus Test (OECD 487, GLP, K, rel. 1): non-clastogenic and
non-aneugenic to human lymphocytes in vitro up to 96 µg/mL.
MLA-hprt (OECD 476, GLP, K, rel. 1): non mutagenic at the hprt locus of L5178Y mouse lymphoma cells up to toxic, or highly toxic concentrations.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Test n° |
Test / Guideline Reliability |
Focus |
Strains tested |
Metabolic activation |
Test concentration |
Statement |
1 (Envigo, 2016) |
Ames Test (OECD 471) K, rel. 1 |
Gene mutation |
TA 1535, TA 1537, TA 98, TA 100 E.coli WP2 uvrA |
-S9 +S9 |
Up to cytotoxic concentration |
-S9 : non mutagenic +S9 : non mutagenic |
2 (Japan Biological Science Centre Genetic Laboratory, 2003) |
Japanese method similar to Ames Test (OECD 471) K, rel. 1 |
Gene mutation |
TA 1535, TA 1537, TA 98, TA 100, E. coli WP2 uvrA |
-S9 +S9 |
Up to cytotoxic concentration |
-S9 : non mutagenic +S9 : non mutagenic |
3 (Envigo, 2016) |
MNT vitro (OECD 487) K, rel.1 |
Chromosomal aberration |
Human lymphocytes |
-S9 +S9 |
Up to cytotoxic concentration |
-S9 and +S9 Not clastogenic -S9 and +S9 Not aneugenic |
4 (Covance, 2016) |
MLA hprt (OECD 476) K, rel. 1 |
Gene mutation | L5178Y mouse lymphoma cells |
-S9 +S9 |
Up to toxic, or highly toxic concentrations |
-S9 : non mutagenic +S9 : non mutagenic |
Gene mutation Assay (Test No. 1, 2 and 4):
Two Bacterial Reverse mutation Assay (Ames test) were performed, according to, and similar to OECD test guideline No 471 with the substance, respectively.
In the first study (1), only in the pre-experiment/experiment I, reduced background growth was observed in the presence of S9 mix at 5000 µg/plate in strains TA 100 and WP2 uvrA. The test substance precipitated in the overlay agar in the test tubes in experiment I from 1000 to 5000 µg/plate in the presence of S9 mix. Precipitation of the test substance in the overlay agar on the incubated agar plates was observed at 5000 µg/plate in experiment I in strains TA 1535, TA 1537, and TA 98 in the presence of S9 mix. The undissolved particles had no influence on the data recording. Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred only in strain TA 100 in all experiments. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with the test substance at any dose level, neither in the presence nor absence of metabolic activation (S9 mix).
In the second study (2), the test substance caused no visible reduction in the growth of the bacterial background lawn at any dose level. The test substance was, therefore, tested up to the maximum recommended dose level of 5000 μg/plate. No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation.
In an in vitro mammalian cell gene mutation test (4) performed according to OECD Guideline 476 and in compliance with GLP, L5178Y tk+/-(3.7.2C) mouse lymphoma cells were exposed to test substance for 3h with six concentrations from 15.63 to 500 µg/mL in the range-finder experiment, with and without S9, and with twelve concentrations from 2.5 to 100 µg/mL without S9 and from 30 to 300 µg/mL with S9 in the Mutation experiment. When tested up to toxic concentrations in the presence or absence of S-9 no statistically significant increases in mutant frequency, compared to the vehicle control MF, were observed following treatment with the test articleat any concentration analysed and there were no statistically significant linear trends, indicating a clear negative result.
It is concluded thatwith the test articledid not induce mutation at thehprtlocus of L5178Y mouse lymphoma cells when tested up to toxic concentrations for 3 hours in the presence or absence of a rat liver metabolic activation system (S-9).
Moreover, the results of a supporting study (Gloxhuber, 1978) are according to the key-studies results.
Chromosomal aberration (Test No. 3):
An in vitro micronucleus test was performed according to OECD Guideline 487 and in compliance with GLP, cultured peripheral human lymphocytes were exposed to test substance in the presence and absence of a metabolic activation system. The test substance was toxic to human lymphocytes. Depending on the preliminary study results, the test substance was therefore tested up to 64 or 96 µg/mL without or with metabolic activation, respectively.
The test substance did not induce any statistically significant increases in the frequency of cells with micronuclei, using a dose range that included a dose level that induced approximately 50% reduction in CBPI in the absence of S9-mix and was the lowest precipitating dose level in the presence of S9-mix.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Harmonized classification:
The substance has no harmonized classification for human health according to the Regulation (EC) No. 1272/2008.
Self classification:
Based on the available data, no additional classification is proposed regarding genetic toxicity according to the Annex VI of the Regulation (EC) No. 1272/2008 (CLP) and to the GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.